This will pave the way for coronavirus inoculation to be tested in minors in the country. In February Bharat Biotech had approached the regulator to conduct Phase III Covaxin trials on children between 5-18 age group. The Subject Expert Committee (SEC) asked the company to submit the interim safety data of Phase II clinical trials before proceeding with Phase III. The trials showed 78% efficacy of Covaxin but the data is yet to be reviewed and published
#covaxin #bharatbiotech #vaccinationforminors


Subscribe The Channel For More News - https://goo.gl/DJAEe9

Check out some of the Great News on ATechnos Reporter
Like * Comment * Share - Don't forget to LIKE the video and write your COMMENT's

Follow Us On
Facebook Page : - https://goo.gl/Q9cQZi
Twitter :- https://goo.gl/jae7FT
G + :- https://goo.gl/Kbk4Y8
-------- About Us -------------

ATechnos Reporter is an emerging allurer and a full-fledged news channel providing content online to keep you updated with the current happenings. It covers almost all the sections like national news, international news, politics, sports, business, tech, auto, social, Life and style, events, education, environment, travel, food recipes etc. We always keep an eye on world technology and latest updates to take our channels to a very advanced level and fulfill the audience expectation. Our sedulous and creative team are working round the clock to match up their preconceived notions.

The content generated is totally authentic and uses today’s modern techniques to gather news. The center of gravity now a day has shifted from print media to online media and people are more inclined towards it. Therefore ATechnos Reporter is on the edge of reaching a new pinnacle and trying to make a loud noise in the news industry.